SAM
XERS icon

Smartleaf Asset Management’s Xeris Biopharma Holdings XERS Stock Holding History

Smartleaf Asset Management’s Portfolio XERS Stock Details XERS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$1.26K Hold
225
– – ﹤0.01% 3076
2025
Q4 		$1.65K Buy
+225
New +$1.77K ﹤0.01% 3041

Other funds holding XERS

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
D.E. Shaw & Co
D.E. Shaw & Co New York $166B AUM 43.98% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Qube Research & Technologies (QRT)
Qube Research & Technologies (QRT) London, United Kingdom $89.9B AUM 20.22% 1-Year Est. Return
RA
Rosalind Advisors Toronto, Ontario, Canada $249M AUM 80.12% 1-Year Est. Return
N
Nuveen Charlotte, North Carolina $369B AUM 31.66% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Smartleaf Asset Management's XERS Position: Q1 2026 in Review

Smartleaf Asset Management held its Xeris Biopharma Holdings (XERS) position steady in Q1 2026 at 225 shares worth $1.26K. The position accounts for ﹤0.01% of the portfolio, ranked #3076.

Smartleaf Asset Management first reported a position in XERS in Q4 2025 and has held it in 2 quarters since. The position peaked at $1.65K in Q4 2025. 237 funds tracked by Wall St. Rank hold XERS as of Q1 2026.

  • Smartleaf Asset Management held 225 shares of Xeris Biopharma Holdings worth $1.26K as of Q1 2026.
  • Smartleaf Asset Management left its Xeris Biopharma Holdings share count unchanged in Q1 2026.
  • Xeris Biopharma Holdings made up ﹤0.01% of Smartleaf Asset Management's portfolio in Q1 2026, its #3076 holding.
  • Smartleaf Asset Management first reported a position in Xeris Biopharma Holdings in Q4 2025 and has held it in 2 quarters since.
  • Smartleaf Asset Management's Xeris Biopharma Holdings position peaked at $1.65K in Q4 2025.
  • 237 funds tracked by Wall St. Rank held Xeris Biopharma Holdings as of Q1 2026.

Based on Smartleaf Asset Management's 13F filing for Q1 2026, filed 15 May 2026.